What are the benefits of single-pill combinations versus free-drug combinations? What is the role of RAS blockers in patients with diabetes or kidney disease? Explore the data underlying these key questions and more in the following animations produced by Novartis.
In this animation, the role of the renin-angiotensin system (RAS) beyond hypertension is explored outlining how it impacts end-organ damage.
Diabetes and hypertension are closely related. In this animation, the benefits of effective hypertension management in patients with diabetes are reviewed.
Review some of the underlying data and the impact ARBs can have in these patients in this animation produced by Novartis.
This Novartis-produced animation explores the advantages of an intensive therapeutic strategy to achieve blood pressure control.
Watch this Novartis-produced overview of the benefits that a single-pill combination therapy can have for your patients’ blood pressure control and treatment adherence.